During the past decade, Hopital Saint André conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 53 clinical trials were completed, i.e. on average, 43.4% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 35 clinical trials were completed. i.e. 74.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Saint André" #1 sponsor was "University Hospital, Bordeaux" with 17 trials, followed by "UNICANCER" with 16 trials sponsored, "Pfizer" with 15 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 10 trials sponsored and "ANRS, Emerging Infectious Diseases" with 10 trials sponsored. Other sponsors include 158 different institutions and companies that sponsored additional 88 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Saint André" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Ministry of Health, France" with 5 trials as a collaborator, "Pfizer" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Incyte Corporation" with 3 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Saint André" are "Melanoma" (9 trials), "HIV-1 Infection" (8 trials), "HIV Infections" (7 trials), "Atopic Dermatitis" (6 trials) and "Colorectal Cancer" (5 trials). Many other conditions were trialed in "Hopital Saint André" in a lesser frequency.

Most popular intervention types in "Hopital Saint André" are "Drug" (159 trials), "Other" (40 trials), "Procedure" (19 trials), "Biological" (18 trials) and "Device" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "radiation therapy" (10 trials), "fluorouracil" (6 trials), "oxaliplatin" (6 trials) and "Avelumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint André" are 216 trials for "All" genders, 8 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Saint André". 2 are not yet recruiting, 35 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 142 completed trials in Hopital Saint André, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint André, 10 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 31 trials that are defined as “Not Applicable".

Hopital Saint André has several departments that took part in Clinical trials: "Hopital Haut-Leveque" - 505 trials